Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with dry eye disease
Signs and symptoms of dry eye disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This study is being conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease. NOTE: All sites have been selected for this study.
Eligible Conditions
- Dry Eye Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Tear Break-up time from baseline to 1 month
Secondary outcome measures
Change in Conjunctival staining score from baseline to 1 month
Change in Cornea staining score from baseline to 1 month
Change in Meibomian gland secretion score from baseline to 1 month
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: TearCareExperimental Treatment1 Intervention
All subjects in the study will undergo the TearCare procedure one time at the baseline visit. They will then be followed out to one month.
Find a Location
Who is running the clinical trial?
Sight Sciences, Inc.Lead Sponsor
12 Previous Clinical Trials
985 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger